Drug intelligence / Profile preview

Phexxi

Development stage
Approved
Lead developer
Evofem Biosciences
Modality
Small Molecules
Administration
Vaginal
01

Overview

Phexxi is an FDA-approved, non-hormonal, on-demand vaginal contraceptive gel developed by Evofem Biosciences. It functions as a vaginal pH modulator, maintaining the acidic environment of the vagina (pH 3.5 to 4.5) even in the presence of alkaline semen, which typically raises vaginal pH to levels conducive to sperm motility. By maintaining acidity, Phexxi inhibits sperm from swimming, thereby preventing fertilization. It is applied via a pre-filled applicator within one hour before vaginal intercourse. The product is also being investigated under the development code GEN-1 (formerly EVO100) for the prevention of certain sexually transmitted infections, including chlamydia and gonorrhea.

Brand names
Phexxi
Other names
lactic acid + citric acid + potassium bitartratelactic acid, citric acid, and potassium bitartrate vaginal gel
02

Targets

Chlamydia trachomatis

Beyond the preview

Go deeper on Phexxi.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phexxi.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call